# TENX (Tenax Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Tenax Therapeutics, Inc. reported $0 in revenue and a net loss of $65.76M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/TENX
- Markdown: https://convexityos.com/fundamentals/TENX.md
- SEC CIK: 0000034956
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000034956&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$69.53M | Operating profit |
| Net Income | TTM | -$65.76M | GAAP bottom line |
| Diluted EPS | TTM | -$1.23 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $113.7M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $32.67M | $12.71M | $3.23M | $5.38M | $25.15M | $4.56M | $3.47M | $1.24M | $3.53M | $13.14M |
| Selling, General & Admin | -- | -- | -- | -- | $7.58M | $5.31M | $5.08M | $5.65M | $5.68M | $6.25M |
| Total Operating Expenses | $56.38M | $19.49M | $8.23M | $11.05M | $32.73M | $9.87M | $8.56M | $6.89M | $9.21M | $52.65M |
| **Operating Income** | -$56.38M | -$19.49M | -$8.23M | $11.05M | -$32.73M | $9.87M | -$8.56M | -$6.89M | -$9.21M | -$52.65M |
| **EBITDA** | -- | -$19.49M | -$8.23M | $11.06M | -$32.72M | $9.87M | -$8.55M | -$6.88M | -$9.19M | -$52.63M |
| Interest Expense | $0 | $23K | $24K | $4.4K | $949 | $1.6K | $0 | -- | -- | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$7.96M |
| **Net Income** | -$52.60M | -$17.60M | -$7.71M | $11.05M | -$32.47M | -$9.85M | -$8.39M | -$14.14M | -$8.84M | -$43.92M |
| Basic EPS | -$1.34 | -$1.15 | -$31.04 | -- | -$1.58 | -$0.95 | -$1.35 | -$9.04 | -$6.27 | -$31.24 |
| **Diluted EPS** | -$1.34 | -$1.15 | -$31.04 | -- | -$1.58 | -$0.95 | -$1.35 | -$9.04 | -$6.27 | -$31.24 |
| Basic Shares Outstanding | 39.2M | 15.3M | 248.4K | -- | 20.6M | 10.4M | 6.2M | 1.6M | 1.4M | 1.4M |
| Diluted Shares Outstanding | 39.2M | 15.3M | 248.4K | -- | 20.6M | 10.4M | 6.2M | 1.6M | 1.4M | 1.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Research & Development | $12.07M | $12.85M | $11.54M | $10.54M | $10.33M | $6.12M | $5.68M | $4.59M |
| Selling, General & Admin | $5.66M | $5.93M | -- | -- | $6.48M | $5.67M | -- | -- |
| Total Operating Expenses | $17.73M | $18.78M | $16.57M | $16.45M | $16.81M | $11.79M | $11.34M | $7.29M |
| **Operating Income** | -$17.73M | -$18.78M | -$16.57M | -$16.45M | -$16.81M | -$11.79M | -$11.34M | -$7.29M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$7.29M |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | -$1.0K |
| **Net Income** | -$16.70M | -$17.80M | -$15.72M | -$15.54M | -$15.80M | -$10.85M | -$10.41M | -$6.27M |
| Basic EPS | -$0.31 | -$0.35 | -$0.35 | -- | -$0.40 | -$0.27 | -$0.28 | -- |
| **Diluted EPS** | -$0.31 | -$0.35 | -$0.35 | -- | -$0.40 | -$0.27 | -$0.28 | -- |
| Basic Shares Outstanding | 53.5M | 50.9M | 45.2M | -- | 39.7M | 39.6M | 36.6M | -- |
| Diluted Shares Outstanding | 53.5M | 50.9M | 45.2M | -- | 39.7M | 39.6M | 36.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $97.60M | $94.90M | $9.80M | $2.12M | $5.58M | $6.25M | $4.91M | $12.37M | $1.60M | $10.00M |
| Short-Term Investments | -- | -- | -- | -- | $0 | $463K | $494K | $495K | $6.12M | $3.28M |
| **Cash & Short-Term Investments** | $97.60M | $94.90M | $9.80M | $2.12M | $5.58M | $6.71M | $5.40M | $12.86M | $7.73M | $13.28M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 | $50K | $73K |
| Other Current Assets | $1.02M | $64K | $252K | $346K | $0 | -- | -- | -- | -- | -- |
| **Total Current Assets** | $104.2M | $96.69M | $11.68M | $3.21M | $5.69M | $6.80M | $6.18M | $13.32M | $8.06M | $13.63M |
| Property, Plant & Equipment, Net | -- | -- | $0 | $7.2K | $7.1K | $6.0K | $6.6K | $8.5K | $9.9K | $19K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $0 | $1.81M | $8.59M |
| Other Non-Current Assets | -- | $0 | $1.0K | $9.6K | $8.4K | $8.4K | $8.4K | $8.4K | $8.4K | $1.11M |
| **Total Non-Current Assets** | $0 | $0 | $1.0K | $196K | $303K | $73K | $184K | $17K | $1.83M | $9.71M |
| **Total Assets** | $104.2M | $96.69M | $11.69M | $3.40M | $5.99M | $6.87M | $6.37M | $13.34M | $9.89M | $23.34M |
| Accounts Payable | $6.04M | $3.16M | $2.07M | $448K | $860K | $758K | $1.66M | $750K | $612K | $728K |
| **Total Current Liabilities** | $7.16M | $4.69M | $3.59M | $1.85M | $1.56M | $2.12M | $2.53M | $1.57M | $1.01M | $6.20M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $64K | $184K | $124K | $60K | $0 | $0 | $0 |
| **Total Liabilities** | $7.16M | $4.69M | $3.59M | $1.91M | $1.75M | $2.24M | $2.59M | $1.57M | $1.01M | $6.20M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $184K | $291K | $60K | $172K | -- | -- | -- |
| Common Stock | $1.0K | $0 | $0 | $3 | $2.5K | $0 | $674 | $379 | $141 | $2.8K |
| Retained Earnings | -$367.5M | -$314.9M | -$297.3M | -$289.5M | -$278.5M | -$246.0M | -$236.2M | -$227.8M | -$213.5M | -$204.7M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | -$70 | $458 | $516 | -$16K | -$19K |
| **Total Stockholders' Equity** | $97.07M | $91.99M | $8.10M | $1.49M | $4.24M | $4.63M | $3.77M | $11.77M | $8.88M | $17.14M |
| Total Equity | $97.07M | $91.99M | $8.10M | $1.49M | $4.24M | $4.63M | $3.77M | $11.77M | $8.88M | $17.14M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $113.7M | $118.0M | $118.8M | $97.60M | $99.40M | $105.5M | $111.4M | $94.90M |
| **Cash & Short-Term Investments** | $113.7M | $118.0M | $118.8M | $97.60M | $99.40M | $105.5M | $111.4M | $94.90M |
| Other Current Assets | $108K | $272K | $107K | $1.02M | -- | -- | $88K | $64K |
| **Total Current Assets** | $117.0M | $121.7M | $123.2M | $104.2M | $102.8M | $105.9M | $112.1M | $96.69M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $117.0M | $121.7M | $123.2M | $104.2M | $102.8M | $105.9M | $112.1M | $96.69M |
| Accounts Payable | $6.57M | $6.79M | $6.35M | $6.04M | $5.61M | $562K | $1.84M | $3.16M |
| **Total Current Liabilities** | $8.36M | $8.07M | $8.49M | $7.16M | $6.60M | $2.53M | $2.77M | $4.69M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $8.36M | $8.07M | $8.49M | $7.16M | $6.60M | $2.53M | $2.77M | $4.69M |
| Common Stock | $5.0K | $3.0K | $2.0K | $1.0K | $1.0K | $0 | $0 | $0 |
| Retained Earnings | -$417.7M | -$401.0M | -$383.2M | -$367.5M | -$351.9M | -$336.1M | -$325.3M | -$314.9M |
| **Total Stockholders' Equity** | $108.7M | $113.6M | $114.7M | $97.07M | $96.21M | $103.3M | $109.3M | $91.99M |
| Total Equity | $108.7M | $113.6M | $114.7M | $97.07M | $96.21M | $103.3M | $109.3M | $91.99M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$52.60M | -$17.60M | -$7.71M | -$11.05M | -$32.47M | $9.85M | -$8.39M | -$14.14M | -$8.84M | -$43.92M |
| Depreciation & Amortization | -- | $0 | $8.0K | $5.1K | $4.1K | $4.1K | $5.0K | $9.0K | $14K | $19K |
| Stock-Based Compensation | $19.16M | $1.12M | $191K | -- | -- | -- | $0 | $190K | $80K | $1.1K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | $2.88M | $1.06M | $1.65M | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$35.80M | -$14.81M | -$5.90M | -$11.39M | -$10.86M | -$9.27M | -$7.56M | -$5.50M | -$12.14M | -$15.87M |
| Capital Expenditure | -- | -- | -- | -$2.3K | -$5.3K | -$3.5K | -$3.6K | -$7.6K | -$4.5K | -$2.9K |
| **Free Cash Flow** | -- | -- | -- | -$11.39M | -$10.86M | -$9.28M | -$7.56M | -$5.51M | -$12.15M | -$15.87M |
| Purchases of Investments | -- | -- | -- | $0 | -$346K | -$597K | -$618K | -$494K | -$299K | -$7.26M |
| **Investing Cash Flow** | -- | $0 | $3.0K | -$2.3K | $453K | $20K | -$1.7K | $7.35M | $3.75M | $22.21M |
| Common Stock Issued | -- | -- | -- | -- | $9.19M | $8.66M | $0 | -- | -- | $0 |
| **Financing Cash Flow** | $38.51M | $99.87M | $13.57M | $7.93M | $9.74M | $10.60M | $96K | $8.91M | $0 | $0 |
| **Net Change in Cash** | $2.71M | $85.06M | $7.67M | -$3.46M | -$666K | $1.34M | -$7.46M | $10.76M | -$8.39M | $6.34M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$16.70M | -$17.80M | -$15.72M | -$15.54M | -$15.80M | -$10.85M | -$10.41M | -$6.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | $3.54M | $3.33M | $2.84M | $4.79M | $5.62M | $4.61M | $4.14M | $970K |
| Change in Payables | -$225K | $449K | $305K | $432K | $5.05M | -$1.28M | -$1.32M | $1.57M |
| **Operating Cash Flow** | -$12.48M | -$14.15M | -$9.31M | -$13.41M | -$9.15M | -$6.26M | -$6.97M | -$3.53M |
| **Investing Cash Flow** | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $8.23M | $13.37M | $30.50M | $11.61M | $3.06M | $278K | $23.56M | $67K |
| **Net Change in Cash** | -$4.25M | -$779K | $21.19M | -$1.80M | -$6.09M | -$5.99M | $16.60M | -$3.46M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -54.2% | -19.1% | -95.2% | 740.0% | -765.1% | -213.0% | -222.5% | -120.2% | -99.5% | -256.3% |
| Return on Assets (ROA) | -50.5% | -18.2% | -66.0% | 324.5% | -541.9% | -143.4% | -131.9% | -106.0% | -89.4% | -188.2% |
| Current Ratio | 14.56x | 20.60x | 3.26x | 1.74x | 3.64x | 3.21x | 2.44x | 8.51x | 7.99x | 2.20x |
| Quick Ratio | 13.64x | 20.22x | 2.73x | 1.15x | 3.57x | 3.17x | 2.13x | 8.21x | 7.71x | 2.15x |
| Debt to Equity | -- | -- | -- | 0.12x | 0.07x | 0.01x | 0.05x | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -174.5% | -- | -431.7% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -169.8% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -60.5% | -57.1% | -50.5% | -54.2% | -45.0% | -30.5% | -22.2% | -19.1% |
| Return on Assets (ROA) | -56.2% | -53.3% | -47.0% | -50.5% | -42.1% | -29.7% | -21.6% | -18.2% |
| Current Ratio | 14.01x | 15.07x | 14.52x | 14.56x | 15.58x | 41.89x | 40.48x | 20.60x |
| Quick Ratio | 13.61x | 14.62x | 14.00x | 13.64x | 15.06x | 41.75x | 40.25x | 20.22x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
